choroidal neovascularization
choroidal neovascularization
Explore linked clinical trials. Standard reference: MONDO:081000022 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002) | Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, age-related macular degeneration, choroidal neovascularization, eye disorder, macular degeneration, optic choroid disorder, retinal degeneration, retinal disorder, uveal disorder, wet macular degeneration | Recruiting | Phase 2 / Phase 3 | 2026-10-02 | NCT07440225 | |
| Speculum-Free Intravitreal Injection Using Cotton-Tipped Applicator Retraction: Pain, Procedure Time, Patient Satisfaction, and Safety | Embolism and Thrombosis, Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Polypoidal Choroidal Vasculopathy, Venous Thrombosis, cardiovascular disorder, choroidal neovascularization, diabetic macular edema, eye disorder, optic choroid disorder, retinal disorder, retinal vein occlusion, thrombotic disease, uveal disorder, vascular disorder | Active, not recruiting | Not applicable | 2026-09-25 | NCT07481500 | |
| A Study to Evaluate the Efficacy and Safety of VIS-101 in Participants With Neovascular Age-Related Macular Degeneration | Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, choroidal neovascularization, eye disorder, macular degeneration, optic choroid disorder, retinal degeneration, retinal disorder, uveal disorder | Not yet recruiting | Phase 2 | 2026-09-10 | NCT07798375 | |
| NG101 AAV Gene Therapy in Subjects With Wet Age-Related Macular Degeneration | Eye Diseases, Hereditary, Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, age-related macular degeneration, choroidal neovascularization, eye disorder, macular degeneration, optic choroid disorder, retinal degeneration, retinal disorder, uveal disorder, wet macular degeneration | Active, not recruiting | Phase 1 / Phase 2 | 2026-09-10 | NCT05984927 | |
| A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003) | Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, age-related macular degeneration, choroidal neovascularization, eye disorder, macular degeneration, optic choroid disorder, retinal degeneration, retinal disorder, uveal disorder, wet macular degeneration | Recruiting | Phase 2 / Phase 3 | 2026-08-06 | NCT07496567 | |
| Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD | Eye Diseases, Hereditary, Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, age-related macular degeneration, choroidal neovascularization, eye disorder, macular degeneration, optic choroid disorder, retinal degeneration, retinal disorder, uveal disorder, wet macular degeneration | Active, not recruiting | Phase 3 | 2026-08-03 | NCT05407636 | |
| Biomarkers and Choroidal Neovascularization | Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, adrenal gland disorder, adrenal gland hyperfunction, central serous chorioretinopathy, choroidal neovascularization, endocrine system disorder, eye disorder, hyperaldosteronism, macular degeneration, optic choroid disorder, retinal degeneration, retinal disorder, uveal disorder | Recruiting | Not stated | 2026-07-07 | NCT04439708 | |
| AVIGA3 (Cohort 2.0) | Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, choroidal neovascularization, eye disorder, macular degeneration, optic choroid disorder, retinal degeneration, retinal disorder, uveal disorder | Recruiting | Not applicable | 2026-06-24 | NCT07255859 | |
| Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD | Eye Diseases, Hereditary, Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, age-related macular degeneration, choroidal neovascularization, eye disorder, macular degeneration, optic choroid disorder, retinal degeneration, retinal disorder, uveal disorder, wet macular degeneration | Active, not recruiting | Phase 2 / Phase 3 | 2026-04-28 | NCT04704921 | |
| Efficacy and Durability of a Personalized Treat-and-extend Regimen of Faricimab for Treatment-naive Polypoidal Choroidal Vasculopathy | Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Polypoidal Choroidal Vasculopathy, age-related macular degeneration, choroidal neovascularization, eye disorder, macular degeneration, optic choroid disorder, retinal degeneration, retinal disorder, uveal disorder | Recruiting | Phase 3 | 2026-03-10 | NCT07461441 | |
| Long-term Study of ADVM-022 in Neovascular (Wet) AMD [OPTIC-EXT] | Eye Diseases, Hereditary, Metaplasia, Neovascularization, Pathologic, Neurologic Manifestations, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, blindness (disorder), choroidal neovascularization, eye disorder, macular degeneration, nervous system disorder, optic choroid disorder, retinal degeneration, retinal disorder, uveal disorder, vision disorder, wet macular degeneration | Active, not recruiting | Not stated | 2026-02-10 | NCT04645212 | |
| Study to Investigate the Efficacy, Safety and Durability of Faricimab in Caucasian Patients With Polypoidal Choroidal Vasculopathy (MONDEGO) | Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Polypoidal Choroidal Vasculopathy, choroidal neovascularization, eye disorder, optic choroid disorder, uveal disorder | Recruiting | Phase 4 | 2026-02-06 | NCT06709339 | |
| Prospective Trial of the Efficacy and Safety of a Personalized Regimen of High-dose Aflibercept 8mg on Treatment-naive Polypoidal Choroidal Vasculopathy: the PALLAS Trial | Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Polypoidal Choroidal Vasculopathy, choroidal neovascularization, eye disorder, optic choroid disorder, uveal disorder | Recruiting | Phase 3 | 2026-02-05 | NCT07389980 | |
| A Prospective, Multicenter, Open-label, Randomized Clinical Trial to Evaluate the Efficacy, Durability, and Safety of Aflibercept 8mg in Different Treatment Regimens in Chinese Patients With Polypoidal Choroidal Vasculopathy (PCV) | Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Polypoidal Choroidal Vasculopathy, choroidal neovascularization, eye disorder, optic choroid disorder, uveal disorder | Not yet recruiting | Phase 4 | 2026-01-26 | NCT07365371 | |
| Impact of Non-Exudative Type 1 MNV on AMD Progression | Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, age-related macular degeneration, choroidal neovascularization, eye disorder, macular degeneration, optic choroid disorder, retinal degeneration, retinal disorder, uveal disorder | Active, not recruiting | Not stated | 2025-12-17 | NCT06125977 | |
| Faricimab Quarterly Maintenance for Neovascular Age Related Macular Degeneration | Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, choroidal neovascularization, eye disorder, optic choroid disorder, uveal disorder | Recruiting | Phase 4 | 2025-10-01 | NCT06742307 | |
| Long Term Efficacy of Faricimab Using a Treat and Extend Regimen for Type 3 Macular Neovascularization | Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, choroidal neovascularization, eye disorder, macular degeneration, optic choroid disorder, retinal degeneration, retinal disorder, uveal disorder | Not yet recruiting | Phase 4 | 2025-09-23 | NCT07187804 | |
| Safety and Efficacy of ADVM-022 in Treatment-Experienced Patients With Neovascular Age-related Macular Degeneration [LUNA] | Metaplasia, Neovascularization, Pathologic, Neurologic Manifestations, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, blindness (disorder), choroidal neovascularization, eye disorder, macular degeneration, nervous system disorder, optic choroid disorder, retinal degeneration, retinal disorder, uveal disorder, vision disorder, wet macular degeneration | Active, not recruiting | Phase 2 | 2025-08-22 | NCT05536973 | |
| The Treatment Burden of Myopic Choroidal Neovascularization | Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, choroidal neovascularization, eye disorder, myopia, optic choroid disorder, refractive error, uveal disorder | Not yet recruiting | Not stated | 2025-06-06 | NCT07009574 | |
| Effect of Video Viewing on Intravitreal Injection Experience | Diabetes Complications, Embolism and Thrombosis, Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Venous Thrombosis, age-related macular degeneration, cardiovascular disorder, choroidal neovascularization, diabetes mellitus, diabetic peripheral angiopathy, diabetic retinopathy, endocrine system disorder, eye disorder, macular degeneration, macular retinal edema, optic choroid disorder, retinal degeneration, retinal disorder, retinal vein occlusion, thrombotic disease, uveal disorder, vascular disorder | Recruiting | Not applicable | 2025-06-03 | NCT07002372 | |
| An Interpretable Fundus Diseases Report Generating System Based On Weakly Labelings | Diabetes Complications, Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, age-related macular degeneration, cardiovascular disorder, choroidal neovascularization, degenerative myopia, diabetes mellitus, diabetic peripheral angiopathy, diabetic retinopathy, endocrine system disorder, eye disorder, macular degeneration, myopia, optic choroid disorder, refractive error, retinal degeneration, retinal disorder, uveal disorder, vascular disorder | Not yet recruiting | Not stated | 2025-04-09 | NCT06918028 | |
| OCT in Rare Chorioretinal Diseases | Aneurysm, Arterial Occlusive Diseases, Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Polypoidal Choroidal Vasculopathy, Retinal Arterial Macroaneurysm, cardiovascular disorder, central serous chorioretinopathy, choroidal neovascularization, eye disorder, hypertensive disorder, hypertensive retinopathy, optic choroid disorder, retinal artery occlusion, retinal disorder, uveal disorder, vascular disorder | Recruiting | Not stated | 2024-02-12 | NCT02141308 |